Eurofins Scientific Societe Europeenne

Eurofins Technologies Announces World’s First AOAC Performance Tested MethodsSM Status for a Screening Method to Detect Aflatoxin M1

Eurofins Technologies (Paris:ERF), a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of aflatoxin M1, I’screen AFLA M1 milk, has been granted AOAC Research Institute Performance Tested MethodsSM status (AOAC Cert. No. 072002) for use with raw bovine whole milk, skim milk and powdered milk.

The assay was developed by Eurofins Tecna, a biotechnology company with 25 years’ experience in mycotoxin screening in food and feedstuffs. Eurofins Tecna is part of the Eurofins Technologies’ group of companies.

Aflatoxins are mycotoxins produced by different strains of Aspergillus, which grow on agricultural commodities, with high moisture content, at relatively high temperatures. Aflatoxin M1 (AFM1) is a derivative of Aflatoxin B1 (AFB1) that is present in the milk of animals that have been fed with AFB1-contaminated feed.

Regulatory limits have been set worldwide for Aflatoxins in food and feed, as well as for AFM1 in milk. AFM1 limits in milk vary in different countries between 0.05 and 0.5 µg/Kg. In the European Union, the limit has been set at 0.05 µg/Kg.

The sensitivity of the I’screen Afla M1 milk assay allows the detection of aflatoxin M1 at concentrations below the regulatory limits set by the European Union. Thanks to the linearity of its dynamic range, it is possible to dilute samples and use the kit in compliance with non-EU regulations, which set concentrations of up to ten times higher than Europe.

The assay is compliant with ISO 14675:2003 (IDF 186:2003).

Receiving the AOAC Performance Tested MethodsSM status demonstrates Eurofins Technologies’ commitment to providing high quality test methods for our food safety customers. The I’screen AFLA M1 milk kit is the first screening method to receive AOAC approval for aflatoxin M1 analysis in milk commodities.

For more information, visit

About Eurofins Technologies

Building on the experience and scientific excellence of the Eurofins Group, Eurofins Technologies is a global provider of diagnostic technologies in the field of bioanalytical testing for the food, feed, environmental, animal health, and clinical diagnostics industries.

About Eurofins – the global leader in bio-analysis

With over 48,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

EN
02/09/2020

Reports on Eurofins Scientific Societe Europeenne

Eurofins Scientific S.E: 1 director

A director at Eurofins Scientific S.E sold 400 shares at 54.720EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC: FY guidance again upgraded after strongest H1 res...

EUROFINS SCIENTIFIC - BUY | EUR125 FY guidance again upgraded after strongest H1 results Results again supported by Covid activities FY guidance again revised upwards

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC: Q1 IMS: Trends that remain largely positive | BUY...

EUROFINS SCIENTIFIC - BUY | EUR125 Q1 IMS: Trends that remain largely positive Good start, ahead expectation Guidance which sounds to us still conservative

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC - BUY | EUR125 FY results: Far beyond management e...

Largely exceed expectations Guidance revisited but sound to us conservative

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC - BUY vs. NEUTRAL | EUR125

EUROFINS SCIENTIFIC - BUY vs. NEUTRAL | EUR125(+33%) Back to Buy recommendation after recent share price consolidation (contact) Good surprises to be expected in the short term… …and the medium term Strong financials allowing the group to remain on the look-out for all opportunities Buy vs Neutral after recent share price consolidation. TP of EUR125 confirmed

ResearchPool Subscriptions

Get the most out of your insights

Get in touch